Kotak Mutual Fund and Motilal Mutual Fund have jointly invested approximately ₹169 crore in Rubicon Research Ltd, acquiring a 2.25% stake ahead of the company's Initial Public Offering (IPO). This strategic move underscores the growing interest in India's pharmaceutical sector, with Rubicon's upcoming IPO aiming to raise ₹1,377.5 crore to fund debt repayment and strategic growth initiatives.